These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 15567077)

  • 1. Meta-analysis shows schizophrenia is not associated with the 40-base-pair repeat polymorphism of the dopamine transporter gene.
    Gamma F; Faraone SV; Glatt SJ; Yeh YC; Tsuang MT
    Schizophr Res; 2005 Feb; 73(1):55-8. PubMed ID: 15567077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine transporter genotype as a risk factor for obesity in African-American smokers.
    Epstein LH; Jaroni JL; Paluch RA; Leddy JJ; Vahue HE; Hawk L; Wileyto EP; Shields PG; Lerman C
    Obes Res; 2002 Dec; 10(12):1232-40. PubMed ID: 12490667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes.
    Shi J; Gershon ES; Liu C
    Schizophr Res; 2008 Sep; 104(1-3):96-107. PubMed ID: 18715757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 10-Repeat 3'-UTR VNTR Polymorphism in the
    Zeng Q; Ning F; Gu S; Zeng Q; Chen R; Peng L; Zou D; Ma G; Wang Y
    Front Genet; 2021; 12():757601. PubMed ID: 34646314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of data associating
    Xu FL; Wu X; Zhang JJ; Wang BJ; Yao J
    Neuropsychiatr Dis Treat; 2018; 14():153-164. PubMed ID: 29379288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis.
    Blum K; Gold MS; Cadet JL; Gondre-Lewis MC; McLaughlin T; Braverman ER; Elman I; Paul Carney B; Cortese R; Abijo T; Bagchi D; Giordano J; Dennen CA; Baron D; Thanos PK; Soni D; Makale MT; Makale M; Murphy KT; Jafari N; Sunder K; Zeine F; Ceccanti M; Bowirrat A; Badgaiyan RD
    Med Res Arch; 2023 Sep; 11(8):. PubMed ID: 37885438
    [No Abstract]   [Full Text] [Related]  

  • 7. Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case-Control Subjects.
    Blum K; Han D; Gupta A; Baron D; Braverman ER; Dennen CA; Kazmi S; Llanos-Gomez L; Badgaiyan RD; Elman I; Thanos PK; Downs BW; Bagchi D; Gondre-Lewis MC; Gold MS; Bowirrat A
    J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting tandem repeats in psychiatric disorders from perspectives of genetics, physiology, and brain evolution.
    Xiao X; Zhang CY; Zhang Z; Hu Z; Li M; Li T
    Mol Psychiatry; 2022 Jan; 27(1):466-475. PubMed ID: 34650204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Meta-analysis of the Association Between SLC6A3 Gene Polymorphisms and Schizophrenia.
    Xu FL; Ding M; Wu X; Liu YP; Xia X; Yao J; Wang BJ
    J Mol Neurosci; 2020 Feb; 70(2):155-166. PubMed ID: 31440993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of recombination hotspots throughout SLC6A3.
    Zhao J; Zhou Y; Xiong N; Qing H; Wang T; Lin Z
    PLoS One; 2019; 14(6):e0218129. PubMed ID: 31185047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study and a systematic meta-analysis of the VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder.
    Grünblatt E; Werling AM; Roth A; Romanos M; Walitza S
    J Neural Transm (Vienna); 2019 Apr; 126(4):517-529. PubMed ID: 30923918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the dopamine hypothesis of schizophrenia in a large-scale genome-wide association study.
    Edwards AC; Bacanu SA; Bigdeli TB; Moscati A; Kendler KS
    Schizophr Res; 2016 Oct; 176(2-3):136-140. PubMed ID: 27338758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-Analysis Reveals Significant Association of the 3'-UTR VNTR in SLC6A3 with Alcohol Dependence.
    Ma Y; Fan R; Li MD
    Alcohol Clin Exp Res; 2016 Jul; 40(7):1443-53. PubMed ID: 27219321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis.
    Faraone SV; Spencer TJ; Madras BK; Zhang-James Y; Biederman J
    Mol Psychiatry; 2014 Aug; 19(8):880-9. PubMed ID: 24061496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between effects of genes coding for dopamine and glutamate transmission on striatal and parahippocampal function.
    Pauli A; Prata DP; Mechelli A; Picchioni M; Fu CH; Chaddock CA; Kane F; Kalidindi S; McDonald C; Kravariti E; Toulopoulou T; Bramon E; Walshe M; Ehlert N; Georgiades A; Murray R; Collier DA; McGuire P
    Hum Brain Mapp; 2013 Sep; 34(9):2244-58. PubMed ID: 22438288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic influences of dopamine transport gene on alcohol dependence: a pooled analysis of 13 studies with 2483 cases and 1753 controls.
    Xu M; Lin Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1255-60. PubMed ID: 21078357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophrenia.
    Wonodi I; Hong LE; Stine OC; Mitchell BD; Elliott A; Roberts RC; Conley RR; McMahon RP; Thaker GK
    Am J Med Genet B Neuropsychiatr Genet; 2009 Mar; 150B(2):282-9. PubMed ID: 18553389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A network of dopaminergic gene variations implicated as risk factors for schizophrenia.
    Talkowski ME; Kirov G; Bamne M; Georgieva L; Torres G; Mansour H; Chowdari KV; Milanova V; Wood J; McClain L; Prasad K; Shirts B; Zhang J; O'Donovan MC; Owen MJ; Devlin B; Nimgaonkar VL
    Hum Mol Genet; 2008 Mar; 17(5):747-58. PubMed ID: 18045777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine genes and schizophrenia: case closed or evidence pending?
    Talkowski ME; Bamne M; Mansour H; Nimgaonkar VL
    Schizophr Bull; 2007 Sep; 33(5):1071-81. PubMed ID: 17630406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family-based study of markers at the 5'-flanking region of the human dopamine transporter gene reveals potential association with schizophrenic psychoses.
    Stöber G; Sprandel J; Jabs B; Pfuhlmann B; Möller-Ehrlich K; Knapp M
    Eur Arch Psychiatry Clin Neurosci; 2006 Oct; 256(7):422-7. PubMed ID: 16783497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.